What is considered a “sequence” for the purpose of assigning sequence identifiers?

According to MPEP 2412.05(a), a “sequence” that requires a separate sequence identifier is defined by WIPO Standard ST.26, paragraph 7, as: An unbranched sequence or a linear region of a branched sequence containing ten or more specifically defined nucleotides, with adjacent nucleotides joined by a 3′ to 5′ (or 5′ to 3′) phosphodiester linkage or…

Read More

What are the symbols and format requirements for nucleotide and amino acid sequence data in patent applications?

The symbols and format requirements for nucleotide and amino acid sequence data in patent applications are outlined in 37 CFR 1.822. This regulation specifies the standards for presenting sequence data in patent applications. It’s important to note that “Appendices A through F referenced in 37 CFR 1.822 are reproduced in MPEP § 2422(I).” These appendices…

Read More

When does MPEP 2412.03(e) apply to patent applications?

The applicability of MPEP 2412.03(e) is clearly stated in the section: “[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]” This means that the definition and requirements for “Modified Nucleotide” apply to patent applications…

Read More